Unichem Laboratories plans to consolidate its US generics business by integrating Bayshore Pharmaceuticals into Unichem Pharmaceuticals (USA).

Unichem Laboratories, an Indian pharmaceutical firm, plans to consolidate its US generics business by integrating Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals (USA) Inc. This strategic move aims to unify all of Ipca Group's US operations. The board will discuss this on September 30, 2024. Following the announcement, Unichem's shares fluctuated, reflecting a recent downturn and a prior increase. The company reported a net profit of Rs 9.26 crore for Q1 FY25.

September 23, 2024
6 Articles